Click here to joinour Electronic Communications.
Listen to a replay of the Immutep “KOL Call on Novel IO Therapy (eftilagimod alpha)” that took place on Wednesday, June 26, 2019
At the cutting edge.
Research for life.
Innovation and performance.
It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
Accurate research is the strong foundation for developing potential in effective treatment.